↓ Skip to main content

Combining conventional therapy with immunotherapy: A risky business?

Overview of attention for article published in European Journal of Cancer (1965), April 2019
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combining conventional therapy with immunotherapy: A risky business?
Published in
European Journal of Cancer (1965), April 2019
DOI 10.1016/j.ejca.2019.02.014
Pubmed ID
Authors

A. Coosemans, A. Vankerckhoven, T. Baert, L. Boon, H. Ruts, M. Riva, S. Blagden, M. Delforge, N. Concin, M.R. Mirza, J.A. Ledermann, A. du Bois, I. Vergote

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 12%
Student > Bachelor 5 12%
Student > Master 4 10%
Student > Doctoral Student 2 5%
Professor 2 5%
Other 7 17%
Unknown 16 39%
Readers by discipline Count As %
Medicine and Dentistry 8 20%
Biochemistry, Genetics and Molecular Biology 5 12%
Immunology and Microbiology 4 10%
Agricultural and Biological Sciences 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 0 0%
Unknown 21 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 June 2020.
All research outputs
#19,954,338
of 25,385,509 outputs
Outputs from European Journal of Cancer (1965)
#5,834
of 6,871 outputs
Outputs of similar age
#265,257
of 365,350 outputs
Outputs of similar age from European Journal of Cancer (1965)
#45
of 63 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,871 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,350 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.